Contact

All Stories

  1. Novel therapy designed to limit brain damage and improve cognitive abilities in Alzheimer’s disease

    Article • Journal of Alzheimer s Disease Reports, December 2023, IOS Press

    Professor Carmen Burtea

  2. Editorial for: “Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole‐body Diffusion‐weighted MR Imaging”

    Article • Journal of Magnetic Resonance Imaging, December 2023, Wiley

    Professor Carmen Burtea

  3. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Professor Carmen Burtea

  4. Molecular and cellular biology of PCSK9: impact on glucose homeostasis

    Article • Journal of Drug Targeting, June 2022, Taylor & Francis

    Professor Carmen Burtea

  5. Editorial for “New Cluster Analysis Method for Quantitative DCE‐MRI Assessing Tumor Heterogeneity Induced by E7130 Treatment to a Breast Cancer Mouse Model”

    Article • Journal of Magnetic Resonance Imaging, May 2022, Wiley

    Professor Carmen Burtea

  6. Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents

    Article • Biology, July 2020, MDPI AG

    Professor Carmen Burtea

  7. Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement

    Article • Materials, June 2020, MDPI AG

    Professor Carmen Burtea

  8. Comparative study of the visual system of two psammophilic lizards (Scincus scincus & Eumeces schneideri)

    Article • Vision Research, June 2020, Elsevier

    Professor Carmen Burtea

  9. Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes

    Article • Biology, March 2020, MDPI AG

    Professor Carmen Burtea

  10. Modulation of adiponectin receptors AdipoR1 and AdipoR2 by phage display-derived peptides in in vitro and in vivo models

    Article • Journal of Drug Targeting, January 2020, Taylor & Francis

    Professor Carmen Burtea

  11. Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa

    Article • Molecules, August 2018, MDPI AG

    Professor Carmen Burtea

  12. Molecular imaging by MRI of brain amyloid burden for Alzheimer's disease diagnosis

    Article • Journal of Alzheimer s Disease, November 2017, IOS Press

    Professor Carmen Burtea

  13. Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1

    Article • Medical Oncology, October 2017, Springer Science + Business Media

    Professor Carmen Burtea

  14. Synthesis, Characterization, and Toxicity Evaluation of Dextran-Coated Iron Oxide Nanoparticles

    Article • Metals, February 2017, MDPI AG

    Professor Carmen Burtea

  15. Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium

    Article • October 2016, Springer Science + Business Media

    Professor Carmen Burtea

  16. Chemical andin vitrocharacterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging

    Article • Contrast Media & Molecular Imaging, July 2016, Wiley

    Professor Sophie Laurent, Professor Carmen Burtea

  17. Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC

    Article • Contrast Media & Molecular Imaging, January 2016, Wiley

    Professor Carmen Burtea

  18. Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cells

    Article • Contrast Media & Molecular Imaging, April 2015, Wiley

    Professor Carmen Burtea

  19. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imag

    Article • Contrast Media & Molecular Imaging, October 2014, Wiley

    Professor Carmen Burtea

  20. Hard corona composition and cellular toxicities of the graphene sheets

    Article • Colloids and Surfaces B Biointerfaces, September 2013, Elsevier

    Professor Carmen Burtea

  21. Significance of cell “observer” and protein source in nanobiosciences

    Article • Journal of Colloid and Interface Science, February 2013, Elsevier

    Professor Carmen Burtea

  22. Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions

    Article • Toxicology Research, January 2013, Oxford University Press (OUP)

    Professor Carmen Burtea

  23. Phage Display Screening for Tumor Necrosis Factor-α-Binding Peptides: Detection of Inflammation in a Mouse Model of Hepatitis

    Article • International Journal of Peptides, January 2013, Hindawi Publishing Corporation

    Professor Carmen Burtea

  24. A Tripodal Ruthenium–Gadolinium Metallostar as a Potential αvβ3Integrin Specific Bimodal Imaging Contrast Agent

    Article • Inorganic Chemistry, June 2012, American Chemical Society (ACS)

    Professor Tatjana N. Parac-Vogt, Professor Wim M De Borggraeve, Professor Carmen Burtea

  25. Development of a Magnetic Resonance Imaging Protocol for the Characterization of Atherosclerotic Plaque by Using Vascular Cell Adhesion Molecule-1 and Apoptosis-Targeted Ultrasmall Superparamagnetic Iron Oxide Derivatives

    Article • Arteriosclerosis Thrombosis and Vascular Biology, June 2012, Wolters Kluwer Health

    Professor Carmen Burtea

  26. Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging

    Article • Contrast Media & Molecular Imaging, March 2012, Wiley

    Professor Carmen Burtea

  27. Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and “Cell Vision”

    Article • PLoS ONE, January 2012, PLOS

    Professor Carmen Burtea

  28. Cell “vision”: complementary factor of protein corona in nanotoxicology

    Article • Nanoscale, January 2012, Royal Society of Chemistry

    Professor Carmen Burtea

  29. A Modular Approach towards the Synthesis of Target-Specific MRI Contrast Agents

    Article • European Journal of Inorganic Chemistry, July 2011, Wiley

    Professor Tatjana N. Parac-Vogt, Professor Wim M De Borggraeve, Professor Carmen Burtea

  30. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library

    Article • Peptides, June 2011, Elsevier

    Professor Carmen Burtea

  31. Preparation and Evaluation of Novel Sugar Dendritic Gd-DTPA Complexes for MRI Contrast Agents and Phospha Sugars for Anti-Tumour Agents

    Article • Advanced Materials Research, April 2011, Trans Tech Publications

    Professor Carmen Burtea

  32. Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease

    Article • Neurobiology of Aging, October 2010, Elsevier

    Professor Carmen Burtea

  33. Ultrasmall particle of iron oxide—RGD peptidomimetic conjugate: synthesis and characterisation

    Article • Bioorganic & Medicinal Chemistry Letters, March 2010, Elsevier

    Professor Carmen Burtea

  34. In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties

    Article • Contrast Media & Molecular Imaging, January 2010, Wiley

    Professor Carmen Burtea

  35. Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents

    Article • Contrast Media & Molecular Imaging, January 2010, Wiley

    Professor Carmen Burtea

  36. Peptidic Targeting of Phosphatidylserine for the MRI Detection of Apoptosis in Atherosclerotic Plaques

    Article • Molecular Pharmaceutics, December 2009, American Chemical Society (ACS)

    Professor Carmen Burtea

  37. How to quantify iron in an aqueous or biological matrix: a technical note

    Article • Contrast Media & Molecular Imaging, November 2009, Wiley

    Professor Carmen Burtea

  38. Magnetic Resonance Molecular Imaging of Vascular Cell Adhesion Molecule-1 Expression in Inflammatory Lesions Using a Peptide-Vectorized Paramagnetic Imaging Probe

    Article • Journal of Medicinal Chemistry, August 2009, American Chemical Society (ACS)

    Professor Carmen Burtea

  39. Molecular imaging of αvβ3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA†

    Article • Cardiovascular Research, January 2008, European Society of Cardiology

    Professor Carmen Burtea

  40. From Phage Display to Magnetophage, a New Tool for Magnetic Resonance Molecular Imaging

    Article • Bioconjugate Chemistry, July 2007, American Chemical Society (ACS)

    Professor Carmen Burtea

  41. A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?

    Article • Bioorganic & Medicinal Chemistry Letters, April 2007, Elsevier

    Professor Carmen Burtea

  42. Pharmacokinetic andin vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity

    Article • Contrast Media & Molecular Imaging, January 2006, Wiley

    Professor Tatjana N. Parac-Vogt, Professor Carmen Burtea

  43. C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI

    Article • Journal of Inorganic Biochemistry, May 2005, Elsevier

    Professor Carmen Burtea

  44. Synthesis, Characterization, and Pharmacokinetic Evaluation of a Potential MRI Contrast Agent Containing Two Paramagnetic Centers with Albumin Binding Affinity

    Article • Chemistry - A European Journal, January 2005, Wiley

    Professor Tatjana N. Parac-Vogt, Professor Carmen Burtea

  45. Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent

    Article • Magnetic Resonance in Medicine, January 2005, Wiley

    Professor Carmen Burtea

  46. Ferritin-induced relaxation in tissues: An in vitro study

    Article • Journal of Magnetic Resonance Imaging, January 2004, Wiley

    Professor Carmen Burtea

  47. Article • Investigative Radiology, June 2003, Wolters Kluwer Health

    Professor Carmen Burtea

  48. Spin–spin relaxation times in myocardial hypertrophy induced by endocrine agents in rat

    Article • Magnetic Resonance Materials in Physics Biology and Medicine, December 1998, Elsevier

    Professor Carmen Burtea